A phase 2 study of S-588410 maintenance monotherapy for platinum-treated advanced or metastatic urothelial carcinoma

Shimizu, N., Hussain, S.A. orcid.org/0000-0003-1552-511X, Obara, W. et al. (7 more authors) (2022) A phase 2 study of S-588410 maintenance monotherapy for platinum-treated advanced or metastatic urothelial carcinoma. Bladder Cancer, 8 (2). pp. 179-192. ISSN 2352-3727

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2022 – The authors. Published by IOS Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (https://creativecommons.org/licenses/by/4.0/).

Keywords: S-588410; cancer peptide vaccine; maintenance therapy; urothelial carcinoma; cytotoxic T lymphocytes
Dates:
  • Published: 3 June 2022
  • Published (online): 3 June 2022
  • Accepted: 6 April 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 14 Aug 2024 09:51
Last Modified: 14 Aug 2024 09:52
Published Version: http://dx.doi.org/10.3233/blc-211592
Status: Published
Publisher: IOS Press
Refereed: Yes
Identification Number: 10.3233/blc-211592
Related URLs:
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics